Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience

L. Moscetti,P. Vici,T. Gamucci, C. Natoli, E. Cortesi,P. Marchetti, D. Santini,R. Giuliani,I. Sperduti, M. Mauri,L. Pizzuti, M.L. Mancini,M.A. Fabbri,V. Magri,L. Iezzi, V. Sini,L. D'Onofrio,L. Mentuccia,A. Vaccaro, S. Ramponi

The Breast（2016）

引用 17|浏览61

暂无评分

摘要

•EVE and EXE combination represents a novel therapy for advanced breast cancer.•Evaluations of toxicities in unselected patients are of interest.•Retrospective analysis in unselected patients has been conducted.•No association between toxicity and previous treatments has been found.

查看译文

关键词

Everolimus,Metastatic breast cancer,Exemestane

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要